Skip to Main Content

Effective July 1, 2025: Revised Payment Policy: Genetic and Molecular Testing Services

Date: 04/21/25

Superior HealthPlan, Ambetter from Superior HealthPlan and Wellcare By Allwell present a revised payment policy to communicate the expansion of requirements for billing molecular and genetic testing services. As a result, the following policy has been created, and is posted on Superior’s Clinical, Payment and Pharmacy Policies webpage for review, prior to its implementation:

Policy

Effective Date

Applicable Products

New Policy Overview or Updated Policy Revisions

Genetic and Molecular Testing Services

(TX.PP.551)

July 1, 2025

Medicaid (STAR, STAR Health, STAR Kids, STAR+PLUS), CHIP, Ambetter from Superior HealthPlan, Medicare (Wellcare By Allwell [HMO, HMO DSNP])

Expansion of the requirements for billing of molecular and genetic testing to advance the reliability of laboratory quality information and reduce variability in billing.

To review all clinical payment or payment policies, please visit Superior’s Clinical, Payment and Pharmacy Polices webpage.

For questions or additional information, please contact Provider Services at: